GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » 3-Year Book Growth Rate

Epigenomics AG (Epigenomics AG) 3-Year Book Growth Rate : -29.00% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Epigenomics AG 3-Year Book Growth Rate?

Epigenomics AG's Book Value per Share for the quarter that ended in Jun. 2023 was $2.42.

During the past 12 months, Epigenomics AG's average Book Value per Share Growth Rate was -89.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -29.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was -29.30% per year. During the past 10 years, the average Book Value per Share Growth Rate was -14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Epigenomics AG was 43.60% per year. The lowest was -41.00% per year. And the median was -10.10% per year.


Competitive Comparison of Epigenomics AG's 3-Year Book Growth Rate

For the Diagnostics & Research subindustry, Epigenomics AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigenomics AG's 3-Year Book Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's 3-Year Book Growth Rate falls into.



Epigenomics AG 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Epigenomics AG  (OTCPK:EPGNF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Epigenomics AG 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigenomics AG (Epigenomics AG) Business Description

Traded in Other Exchanges
Address
Geneststrasse 5, Berlin, BB, DEU, 10829
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines